Shots:
- CPBIO’s expanding global footprint is powered by a science-led strategy that connects innovation, partnerships, and emerging market growth with a core goal: turning evidence-based R&D into practical solutions that improve livestock productivity, resilience, and sustainability.
- The company delivers species-specific solutions across poultry, swine, ruminants, and aquaculture while following a unified R&D philosophy focused on preventive health, efficiency, and responsible antibiotic alternatives, supported by advanced science, digital insights, and validation within CP Group’s integrated value chain.
- PharmaShots welcomes Gary Yang, President of Global Sales and Marketing at CPBIO, for a conversation on the company’s innovation roadmap, technology integration, and global vision for advancing sustainable, science-driven animal health solutions.
Saurabh: CPBIO has been quite active recently, from innovation showcases to global engagements. What’s been the driving focus behind these initiatives, and how do they reflect where CPBIO is headed next?
Gary: The driving focus behind CPBIO’s recent initiatives has been to strengthen our position as a science- driven, globally relevant animal health company. Our innovation showcases and international engagements are not isolated activities, but part of a long-term strategy to connect R&D, manufacturing, and real-world farming needs.
These initiatives reflect our direction toward more evidence-based solutions, deeper collaboration with global partners, and a stronger presence in emerging markets. Moving forward, CPBIO will continue to invest in innovation platforms that translate science into practical, scalable value for livestock producers worldwide.
Saurabh: CPBIO works across diverse animal health segments, including poultry, swine, ruminants, and aquaculture. How do you approach innovation differently across these segments while maintaining a unified R&D philosophy?
Gary: Each animal segment presents distinct biological and management challenges, So CPBIO adopts a targeted innovation approach tailored to species-specific needs. For example, poultry solutions emphasize gut health and stress management, while swine and ruminant programs focus more on immunity, metabolic balance, and productivity resilience.
At the same time, our unified R&D philosophy is built on common scientific principles: preventive health, efficiency enhancement, and sustainability. This allows us to customize solutions at the application level while maintaining consistency in research rigor, safety standards, and product development logic across all segments.
Saurabh: Technology is increasingly shaping modern animal health solutions. How is CPBIO Bioleveraging advanced science or digital tools to address evolving disease and productivity challenges?
Gary: CPBIO actively integrates advanced science such as formulation technology, precision nutrition concepts, and functional ingredients into product development. These technologies help improve bioavailability, stability, and overall efficacy under diverse farm conditions.
In parallel, we are gradually adopting digital tools to support R&D decision-making, technical services, and market feedback loops. By combining scientific innovation with data-driven insights, CPBIO aims to respond more efficiently to evolving disease pressures and productivity demands.
Saurabh: Being part of the broader CP Group ecosystem is a unique advantage. How does this integrated value chain help CPBIO accelerate innovation and deliver more holistic solutions to customers?
Gary: As part of the CP Group ecosystem, CPBIO benefits from a fully integrated value chain that is actively utilized within the group itself. This internal application across breeding, feed, and farming operations allows us to validate innovations in real production environments and continuously refine solutions based on practical performance and operational feedback.
Through close collaboration across the value chain, CPBIO is able to develop more systematic and application-driven solutions that go beyond animal health alone, while also supporting productivity improvement, cost efficiency, and the long-term sustainability of farming operations.
Saurabh: As CPBIO expands globally, consistency and quality become critical. How do you ensure your products meet high standards across different markets and geographies?
Gary: CPBIO follows unified global quality systems covering raw materials, manufacturing, and finished products. These standards are aligned with international regulatory requirements and are consistently applied across all production sites.
In addition, we adapt to local regulatory frameworks and market needs through strong technical support teams and localized validation. This balance between global standards and local adaptation ensures consistent quality while remaining relevant in diverse markets.
Saurabh: Animal health needs are evolving rapidly, especially under cost and disease pressures. What key trends are shaping CPBIO’s product roadmap over the next few years?
Gary: Key trends shaping CPBIO’s product roadmap include a stronger emphasis on preventive health, efficiency-driven solutions, and alternatives that support responsible antibiotic use. Cost control and resilience against disease challenges are becoming central considerations for producers worldwide.
In response, CPBIO is focusing on products that improve gut health, immunity, stress management, and overall performance, helping customers achieve sustainable productivity under increasing pressure.
Saurabh: What upcoming milestones or innovations should the industry watch out for from CPBIO?
Gary: The industry can expect CPBIO to continue expanding its innovation pipeline, with new solutions addressing stress management, gut health, and productivity optimization across species. We are also strengthening our global presence through deeper regional engagement and strategic partnerships.
These milestones reflect CPBIO’s commitment to long-term innovation, global relevance, and delivering practical value to the animal health industry.
About the Author:
Gary Yang
President of Global Sales and Marketing at CPBIO
Gary Yang is President of Global Sales and Marketing at CPBIO. He has extensive experience in the animal health industry, with a strong background in global business development and commercial strategy. In his role, Gary focuses on aligning innovation, manufacturing, and market needs to support CPBIO’s long-term growth and its commitment to delivering reliable, science-based solutions for animal production.
